Cross-Border Merger Remedies Demand Coordinated Divestiture Strategies

Rising parallel enforcement by the FTC, DOJ, European Commission, and UK CMA is forcing merging parties to negotiate overlapping but inconsistent remedies—divestiture buyers, asset scopes, and timing often diverge by jurisdiction. Recent matters show agencies rarely defer to one another's analyses, increasing the risk that a remedy accepted in one forum triggers non-compliance in another. Practitioners recommend early pre-clearance mapping of likely remedy demands, harmonized purchaser searches, and explicit carve-outs in consent decrees to preserve flexibility. In-house counsel should build cross-border remedy playbooks before signing, identify jurisdiction-specific deal-breakers, and engage local counsel in parallel to stress-test divestiture commitments against each agency's stated preferences and recent precedent.